| |
Atrial fibrillation
|
No atrial fibriallation
|
Chi-square/df/p or t/d.f/p
|
|---|
|
N
|
46
|
108
| |
|
HbA1c (%)
|
5.9 ± 0.3*
|
5.7 ± 0.4
|
1.953/139/0.05
|
|
Insulin (pmol/l)
|
98 ± 67
|
90 ± 39
|
0.887/120/0.38
|
|
HOMA-IR
|
4.35 ± 3.4
|
4.0 ± 1.9
|
0.730/120/0.47
|
|
Fasting glucose (mmol/l)
|
5.3 ± 0.6
|
5.3 ± 0.6
|
0.156/152/0.88
|
|
Delta 1-h glucose (mmol)l)
|
4.3 ± 2.2
|
3.9 ± 1.9
|
-1.299/152/0.20
|
|
Delta 2-h glucose (mmol/l)
|
2.0 ± 2.2
|
1.4 ± 1.6
|
-0.167/152/0.10
|
|
AUC Baseline-60 minutes
|
129.7 ± 65.6
|
116.1 ± 57.2
|
-1,299/152/0.20
|
|
AUC 60–120 minutes
|
193.2 ± 102.0*
|
161.1 ± 85.5
|
-2,010/152/0.05
|
|
OGTT results and the metabolic syndrome, n (%)
|
|
NGT
|
28 (60.9%)
|
61 (56.5%)
|
6.143/2/0.46
|
|
Prediabetes
|
12 (26.1%)
|
43 (39.8%)
| |
|
DM
|
6 (13.0%)
|
4 (3.7%)
| |
|
Metabolic syndrome
|
19 (41.3%)
|
34 (31.5%)
|
1.379/1/0.240
|
- *: p ≤ 0.05 Abbreviations: HbA1c – Haemoglobin A1c, HOMA-IR – homeostasis model assessment for insulin resistance, h – hour, AUC – area under the curve, OGTT – oral glucose tolerance test, NGT – normal glucose tolerance, DM – diabetes mellitus
